Neximmune Inc
NASDAQ:NEXI 12:38:12 PM EDT
Earnings Announcements
NexImmune Reports First Quarter 2022 Financial Results And Provides Business Updates
Published: 05/12/2022 21:05 GMT
Neximmune Inc (NEXI) - Neximmune Reports First Quarter 2022 Financial Results and Provides Business Updates.
Q1 GAAP Loss per Share $0.66.
Neximmune - Expects Existing Cash, Cash Equivalents, Marketable Securities to Enable to Fund Operating, Capex Requirements Into Q2 of 2023.
Q1 GAAP Loss per Share $0.66.
Neximmune - Expects Existing Cash, Cash Equivalents, Marketable Securities to Enable to Fund Operating, Capex Requirements Into Q2 of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.72
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.61
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.72
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.61
More details on our Analysts Page.